Hongyu Pan
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 4
-
- RNA modifications and cancer 9
- RNA Research and Splicing 6
- Ubiquitin and proteasome pathways 4
-
- Neurogenesis and neuroplasticity mechanisms 4
-
- Plant-Microbe Interactions and Immunity 4
- Plant pathogens and resistance mechanisms 4
- Partner nations
- ChinaUnited StatesBulgaria
In The Last Decade
Hongyu Pan
29 papers receiving 671 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 273
- Molecular Biology 468
- Developmental Neuroscience 25
- Neurology 34
- Oncology 89
Countries citing papers authored by Hongyu Pan
This map shows the geographic impact of Hongyu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyu Pan more than expected).
Fields of papers citing papers by Hongyu Pan
This network shows the impact of papers produced by Hongyu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyu Pan. The network helps show where Hongyu Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongyu Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 46 | |
| 10 | 2020 | 16 | |
| 11 | 2019 | 78 | |
| 12 | 2018 | 10 | |
| 13 | 2018 | 31 | |
| 14 | 2018 | 13 | |
| 15 | 2018 | 109 | |
| 16 | 2018 | 9 | |
| 17 | 2017 | 142 | |
| 18 | 2017 | 19 | |
| 19 | 2017 | 12 | |
| 20 | The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. | 2012 | 13 |
About Hongyu Pan
Hongyu Pan is a scholar working on Developmental Neuroscience, Cancer Research and Endocrinology, having authored 30 papers that have together received 674 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (7 papers), RNA Research and Splicing (6 papers), Plant-Microbe Interactions and Immunity (4 papers), MicroRNA in disease regulation (4 papers), Ubiquitin and proteasome pathways (4 papers), Plant pathogens and resistance mechanisms (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). The work is most often cited by research in Cancer Research (273 citations), Molecular Biology (468 citations) and Developmental Neuroscience (25 citations). Hongyu Pan has collaborated with scholars based in China, United States and Bulgaria. Frequent co-authors include Mingxia Yan, Ming Yao, Hechun Lin, Miaoxin Zhu, Geng Qin, Tao Yu, Jinliang Liu, Binggui Sun, Jing Li and Lei Liu. Their work appears in journals such as Cancer Research, The FASEB Journal and New Phytologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.